PLACE OF SURGERY IN OPISTHORCHIASIS CHOLANGIOCARCINOMA

Similar documents
Multiple Primary Quiz

Hilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht

Contemporary Imaging of Biliary Malignancy and Preoperative Evaluation

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital

R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary

Cholangiocarcinoma (Bile Duct Cancer)

Liver Tumors. Prof. Dr. Ahmed El - Samongy

To describe the liver. To list main structures in porta hepatis.

Gastroenterology Tutorial

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Imaging in gastric cancer

Biliary tree dilation - and now what?

Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction

Cholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD

Ultrasonography in the Surgical Treatment

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI

PATHOLOGY MCQs. The Pancreas

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Obstructive Jaundice; A Clinical Study of Malignant Causes.

Surface Anatomy. Location Shape Weight Role of Five Surfaces Borders Fissures Lobes Peritoneal Lig

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Original article: new surgical approaches to the Klatskin tumour

Radiology- Pathology Conference 4/29/2012. Lymph Nodes. John McGrath

Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma

Pancreas Case Scenario #1

Cholelithiasis (Gallstones)

Liver and Pancreatic Case discussion

Safe Answers For The American Board of Surgery Certifying Exam & Recertifying Exam

Pancreas & Biliary System. Dr. Vohra & Dr. Jamila

Endoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy

BILIARY TRACT & PANCREAS, PART II

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Gallbladder Cancer and Cholangiocarcinoma. Yuman Fong, MD Upper Gastrointestinal Cancer Seminar Copenhagen, Denmark 2009

Neoplasms of the Canine, Feline and Lemur Liver:

Case Scenario 1. Discharge Summary

Rokitansky-Aschoff sinuses are epithelial invaginations in the gallbladder wall that from as a result of increased gallbladder pressures.

Case Report Solitary Osteolytic Skull Metastasis in a Case of Unknown Primary Being latter Diagnosed as Carcinoma of Gall Bladder

To evaluate 792 patients with malignant biliary obstruction after inner-stents drainage procedure

Personal Profile. Name: 劉 XX Gender: Female Age: 53-y/o Past history. Hepatitis B carrier

Bronchogenic Carcinoma

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Radiology Pathology Conference

Anatomy of the biliary tract

Afternoon Session Cases

Case Reports. Intraductal Papillary Cholangiocarcinoma: Case Report and Review of the Literature INTRODUCTION CASE REPORT

Trends in Liver Cancer Incidence between 1985 and 2009, Khon Kaen, Thailand: Cholangiocarcinoma

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

Intrahepatic Cholangiocarcinoma (ICC) Detected by Sonography

X-Ray Corner. Imaging Approach to Cystic Liver Lesions. Pantongrag-Brown L. Solitary cystic liver lesions. Hepatic simple cyst (Figure 1)

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Development of the Liver and Pancreas

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

GALLBLADDER CANCER. Lidie M. Lajoie MD Downstate Surgery M&M July 21, 2011

Surgical anatomy of the biliary tract

Cholangiocarcinoma. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist)

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Liver Transplantation

RESEARCH ARTICLE. Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation

Biliary cancers: imaging diagnosis. Study of 30 cases

Pancreas composed of 2 parts: 1- exocrine gland 2- endocrine gland

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung

Images In Gastroenterology

Surgical Treatment for Periampullary Carcinoma A Study of 129 Patients*)

Lecture 02 Anatomy of the LIVER

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

PARASITOLOGY CASE HISTORY 12 (HISTOLOGY) (Lynne S. Garcia)

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons

Management of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation

Pancreas and Biliary System

Gastrinoma: Medical Management. Haley Gallup

QUESTIONS for the examination in surgery for 4 th -year students of the Faculty of foreign students

Index. Note: Page numbers of article titles are in boldface type.

PANCREAS DUCTAL ADENOCARCINOMA PDAC

Pre-operative assessment of patients for cytoreduction and HIPEC

Gallbladder Cancer. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist)

PANCREATIC CANCER GUIDELINES

pitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:

Surgical Treatment of special Tumours. Winnie Achilles Tierklinik Hollabrunn Lastenstrasse Hollabrunn

GASTROINTESTINAL IMAGING STUDY GUIDE

Pathology of the Liver and Biliary Tract 5 Diseases of the Biliary Tract. Shannon Martinson, March 2017

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Workup of a Solid Liver Lesion

Topics: Staging and treatment for pancreatic cancer. Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems

State of the Art Imaging for Hepatic Malignancy: My Assignment

T of patients with malignant melanoma

MALIGNANT HEPATIC NEOPLASMS: USING ULTRASONOGRAPHY AS A MEANS OF DEFINING HEPATIC LESIONS. 1.5 Contact Hours. Presented by: CEU Professor 7

CHOLANGIOCARCINOMA (CCA)

Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma

Follow up CT Findings of Various Types of Recurrence after Curative Gastric Surgery 1

Establishment and Characterization of a Cholangiocarcinoma Cell Line from a Thai Patient with Intrahepatic Bile Duct Cancer

Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

Early Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

NAACCR Webinar Series 1

I patients with nonendocrine pancreas carcinoma

Hematologic Malignancies of the Liver : Spectrum of Disease. Zhou Jian

Transcription:

PLACE OF SURGERY IN OPISTHORCHIASIS CHOLANGIOCARCINOMA ASSOCIATED Vajarabhongsa Bhudhisawasdi Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand The northeastern part of Thailand, commonly called "Esan", is an endemic area of Opisthorchis viverrini (Upatham et al, 1984). This area is also well-known among surgeons and pathologists for the strong relationship between cholan-giocarcinoma and opisthorchiasis. In Bangkok nearly all of cases of cholangiocarcinoma occur in workers from Esan who migrated to Bangkok and all had liver flukes in their biliary tracts. The largest autopsy case report, from Siriraj Hospital (Koompirochana et al, 1978), also shows this relation. Opisthorchiasis by itself cannot produce cholangiocarcinoma, This is indirectly proved in. experimental animals (Bhamarapravati et al, 1978; Thamavit et al, 1978; Flavell and Lucas, 1983; Thamavit et al, 1987). But opisthorchiasis and nitrosamine compounds induce cholangiocarcinoma. "Plarah" (a kind of fermented fish), the popular and regular food of native people of Esan, is very rich in nitrosamine compounds. Recently, provincial-based cancer registration (Vatanasapt et al, 1988) and hospital-based study (Green et al, 1990), have clearly convinced us that cholangiocarcinoma has a very high incidence rate in Northeast Thailand and is one of the biggest health problems of Thailand, it seems that opisthorchiasis acts as a strong promoter of cholangiocarcinoma, As a general surgeon who has worked in the middle part of Northeast Thailand since 1976 and has a special interest in cholangiocarcinoma, I present my experience and impressions about Opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA). Surgical patholgy OV-CCA in Northeast Thailand has its own definition as an adenocarcinoma arising from epithe- lia of the biliary trees. This includes both intraand extra-hepatic portions. (Those arising from gall bladder and ampulla of vater are excluded). OV-CCA is a mucin-producing adenocarcinoma. Mucin can be seen by special staining, both intra - and extra-cellular. This type of tumor usually spreads through the lymphatic system to the cystic nodes, the common bile duct nodes, the celiac nodes and then to the left supraclavicular nodes. Left lobe tumors may spread directly to the celiac nodes. There are two types of OV-CCA: Peripheral type: The tumor originates in the cholangiole or small peripheral bile ducts. Its cut surface is greyish-white and shiny from its mucinous content. It may be multiple or single and be confined to one lobe or both lobes of the liver. It tends to have umbilication on its surface and has a tendency to have central necrosis. Some tumors produce humoral substances that cause pyrexia or induce deep vein thrombosis. The tumor has a tendency to adhere to the surrounding structure so that direct invasion to the diaphragm, the rib cage, the gall bladder, the colon and the stomach is not uncommon. and the ribs, the tumor may disseminate From the diaphragm via the lymphatie system to the paravertebral lymphatic chain and the parasternal lymph chain or via the vertebral venous plexus to the vertebrae, the skull, the pelvis and the brain. It may have hematogenous spreading to distant structures the long bones. Transcelomic in late stages. Central type: The carcinoma ducts, both intra and extra-hepatic. such as the skin in remote areas and site is the hilar region (The confluence left hepatic ducts at the porta hepatis) spread is usually present arises from the large bile The most common of the right and (Table I). This 85

lesion may be confused with the peripheral that invades the porta hepatis. type lesion pure hilar lesion 34 cases-(27.2%) 20 cases (16.0%) Table I The site of central type cholangiocarcinoma (based on 125 obstructive jaundice cases from OV-CCA). pure middle lesion 11 cases (8.8%) 5 cases (4.0%) Site No. of cases % Hilar 54 43.2 Cystic duct junction 16 12.8 Distal common bile duct 25 20.0 Skip lesion 12 9.6 Diffused lesion 18 14.4 The unique feature of this type is skip lesions, that is two distant lesions separated In operations by a normal duct. the second lesion at the hilar or intrahepatic duct is often missed if careful bile duct exploration is not carried out. The tumors have a tendency to invade surrounding structures at earlier stages than peripheral types. The tendency to spread submucosally and invade of the hepatic artery or the portal vein in the hepatoduodenal ligament makes complete removal of the tumor unlikely. Lymphatic spreading to cystic lymph nodes and the common bile duct nodes is common but transcelomic in the peripheral spread often occurs in later stages than type. The combination of the peripheral and central types is usual. In 125 cases of obstructive jaundice, only 73 cases (58.4%) were the pure central type and another 52 cases were the combination of central and peripheral types (Fig I). of various forms The gross appearance of central type cholangiocarcinoma has three forms: nodular, infiltrative and polypoid masses (Weinbren and Mutum, 1983). The last one tends to have a better prognosis because tumor invasion to surrounding structures is less. pure distallesion 14 cases (17.2%) 11 cases (8.8%) pure skip lesion 5 cases (4.0%) 7 cases (5.6%) pure diffused lesion 9 cases (7.2%) 9 cases (7.2%) Fig 1 - Combinations of various types of cholangiocarcinoma in 125 obstructive jaundice cases. Gall bladder pathology in OV-CCA is always determined by the site of obstruction, the presence of cystic duct obstruction and secondary infection. These factors cause the following features of gall bladder: I. Collapsed and empty gall bladder because the site of obstruction is above the cystic duct junction. 2. Hydrops or mucocele of the gall bladder due to cystic duct obstruction either from tumor at the cystic duct junction or secondary deposits from hilar or distallesions. 3. Distal bile duct obstruction with patent cystic duct causes distended gall bladders, often full of green bile. 86

4. Acute acalculous cholecystitis, gangrenous gall bladder and empyema of gall bladder are secondary to cystic duct obstruction and secondary infection. It is not uncommon that the gall bladder may be invaded by the nearby tumor or distended by blood from bleeding ductal tumors (Table 2). In OV-CCA, not only the presence of dead or viable flukes or their eggs in the bile but the characteristic appearance of chronic O'V-infected livers ("superficial bile lake dilatation") is always observed, especially in obstructive jaundice cases (Ninety-seven of 125 cases (77.6%) had this appearance). Table 2 Gall bladder pathology observed in 125 obstructive jaundice cases from cholangiocarcinoma. Gall bladder pathology No. of cases % Collapsed 33 26.4 Hydrops 38 30.4 Distended 26 20.8 Inflamed 4 3.2 Empyema 8 6.4 Gangrenous 2 1.6 Tumor-invaded 2 1.6 Blood-filled I 0.8 Contracted 5 4.0 Removed 6 4.8 Clinical picture OV-CCA affects men more than women; the ratio is about 2-3 : l. The peak age-group is 46-60 years and nearly all are natives of "Esan" who live in rural villages. Very few cases live in urban areas and we have never seen a single case in Vietnamese Chinese. Eighty-five percent of the patients are farmers and all are regular consumers of "Plarah", the food that is very rich in nitrosamine compounds. There are six forms of clinical presentation: 1. Obstructive jaundice. This is the most common presentation. Eighty to ninety percent of malignant obstructive jaundice cases in Northeast Thailand are or caused by OV-CCA and the common picture is a walking jaundice case with a large liver. The gall bladder may be palpated or not depending on the site of obstruction. Most of them have history of jaundice and dark urine for more than 2 weeks, half of them has abdominal pain, about one third present as a complicated obstructive jaundice such as acute cholangitis, septic shock, acute renal failure, hepatic failure and spontaneous bleeding. This form of presentation accounts for about 60-70% of OV-CCA. 2. Liver mass. This is the second most common form of presentation and accounts for about 20-30% of OV-CCA cases. The tumors may be solitary or multiple and have to be differentiated from hepatomas but 90-95% of the primary liver tumor cases in "Esan" are peripheral-type cholangiocarcinoma. Alfa fetoproteins are negative in OV-CCA, but most of the cases have high nonspecific CEA levels and are not related to hepatitis B virus. Age and sex patterns a re the same as obstructive jaundice cases and also present in late stages. Most tumor sizes are larger than 6 ems in diameter and have already invaded surrounding structures especially the diaphragm. This form of presentation is increasing. 3. Hydrops of the gall bladder. The patient is nonjaundiced but has a tensed palpable gall bladder. Formally this form of presentation was believed to be an earlier phase of obstructive jaundice but this is not true. The stage of the tumor is often advanced. Components of cystic duct obstruction than common bile duct obstruction. are more dominant 4. Acute acalculous cholecystitis. In endemic areas of OV-CCA this presentation is not uncommon. The common victims are middle-aged men. This condition has a sex ratio of about 4: 1 and OV-CCA is often missed because the surgeon usually concentrates on removing the diseased gall bladder and is unaware of the latent bile duct obstruction and this often reveals itself 2-4 weeks after "successful cholecystectomy." 5. Incidental findings. This presentation is explained by the fact that small liver tumors do not cause any symptoms in most of the cases and central type tumors take a long time before they completely obstruct the bile duct and cause obstructive jaundice. These lesions may cause only dyspepsia or upper abdominal discomfort but these symptoms are minor and nonspecific. 87

Nevertheless some of these small and latent tumor may cause bizarre presentations. 6. Miscellaneous. There are a group of presentations caused by distant metastatic lesions, such as: pathological fracture of the long bone subcutaneous nodules brain and retrobulbar metastasis lytic lesion of the right twelfth rib lytic lesion of the skull or the pelvis paraplegia due to cord compression Some tumors release humoral substances that cause pyrexia deep vein thrombosis Treatment Up to now the mainstay of treatment of OV-CCA has been surgery. The surgery aims to remove as much as possible of the tumor tissue and maintain the function of hepatobiliary system. Other modalities of treatment are not promising. In obstructive jaundice cases, curative treatment "is unlikely because of late presentation and because the nature of the tumor makes complete removal of the tumor very difficult. In Only 21 of 125 cases (16.8%) could the tumors be removed, but surgery offers good and reasonable palliative treatment. The common surgical operations are 1. tumor resection and bypass; 2. bypass alone using many variety of enterobiliary anastomosis; 3. external drainage. This is usually the last resource in surgical treatment. The surgery in unselected patients has high morbidity and mortality so pre-operative risk factors should be identified. A prospective study was conducted on 125 unselected patients (whose data is the main source of information for this handout) by using univariate analysis. Eight pre-operative risk factors were identified (Table 3). But from multivariate and serum alkaline phosphatase are the factors that can predict the outcome of surgery. Preoperative Table 3 risk factors in 125 obstructive jaundice cases from cholangiocarcinoma. 1. Hematocrit s 30% 2. Neutrophil in white cell count> 80% 3. Serum albumin :5 2.7 g% 4. Prothrombin activity :5 85% 5. Serum creatinine> 3.0 mg% 6. BUN> 30 mg% 7. Serum alkaline phosphatase> 10 SUo 8. Serum SOOT> 150 IV. There are conditions that complicate the pre-, peri-and postoperative courses of obstructive jaundice patients from OV-CCA. 1. Bleeding tendency. This common condition is due to coagulopathy from prothrombin complex deficiency. The second cause is prolonged P1T from hepatocholangitis secondary to biliary sepsis. The bleeding tendency is very rarely caused by platelets dysfunction due to azothemia and usually had a poor prognosis. 2. Biliary sepsis. This condition, if uncontrollable or poorly managed, may lead to other complications. Suppurative cholangitis is a consequence of longstanding obstruction or small and obstructed enterobiliary anastomosis. A common causative organism is E. coli. The second most common is Klebsiella. In immunocompromised hosts or poorly managed cases super-infection by Candida albicans is not uncommon. 3. Renal failure. This condition may be caused by inadequate hydration, use of aminoglycosides and biliary sepsis. Endotoxin theory seems to fit well in OV-CCA cases. 4. Upper GI hemorrhage. Commonly caused by gastritis secondary to stress or sepsis. Uncommonly caused by bleeding from a pre-existing peptic ulcer. Coaggulopathy makes the treatment of this complication very difficult. Rare bleeding from gastric varices or duodenal varices has a very poor prognosis. 5. Hepatic failure. This complication is usually due to a neglected case of obstructive jaundice and nearly all of them have biliary sepsis. Surpisingly this complication is uncommon. 88

The principle causes of death in OV-CCA are I. uncontrollable biliary sepsis 2. massive upper GI hemorrhage 3. acute renal failure Long term survival in obstructive jaundice from OV-CCA is rare. Most surgery is palliative. Nevertheless, at least 2 cases of 125 cases had 5 years' survival. The quality of life in the first months after surgery were satisfactory and well-accepted by the patients and their families. As for the survival curve from 125 unselected patients, including those who died postoperatively, 50% proportional survivality is about 90 days. The one year survival rate is around 15% The factors that predict better prognosis are type and stage of the lesion, and proper internal bypass (Figs 2, 3, 4). Skip and diffused lesions, external drainage, and unilateral peripheral bypass have very poor prognosis. % p r o b 5 u r v I v I I t Y Site of lesion ~~---------j --Skip lesion -- Dletal lesion ~W~-----------l -- Middle lesion -- Diffused, Ion -- Hllar lesion 100 200 300 400 500 Survival time (days) 600 700 Fig 4 - Obstructive jaundice from OV-CCA. 125 personal cases Nov 1982 - Nov 1985. Treatment ofliver mass is surgical removal of the mass by varieties of hepatectomy. In general this has better prognosis than obstructive jaundice cases. Postoperative morbidities and complications are few and postoperative mortality are rare. This may be due to proper selection of the patients and good surgical technics. Hepatectomy are done even in the cases that had distant metastases or where the tumor had invaded the diaphragm. But where the size of the tumor is larger than 6 ems or has already invaded surrounding structures, recurrence of the tumor is common. The tumour spreads more rapidly than in properly resected cases. 012345 6789W"~gU~~"Wwro~~ SURVIVAL TIME AFTER OPERATION Fig 2 - The survival curves of 125 obstructive jaundice cases from OV-CCA Nov 1982-Nov 1985. MONTHS Much progress have been made during the last 3 years, especially in unstanding the process of carcinogenesis, but there are many things still to be learned. REFERENCES ~ 100 go 80 S It 7. iil 60... ~ 50 ~ 40 It 3. ~ 20..,. '" -. -'-. KAPLAN o 1 2 3 of 5.78'W"~gU~~"w~~nn SURVIVAL TIME AFTER OPERATION - ME/ER LIFE TABLE - STAGE IC 10 CASES ------ STAGE UI 23 CASES - - - - STAGE t!z 91 CASES Fig 3-125 Obstructive jaundice cases from cholangiocarcinoma Nov 1982 - Nov 1985. MONTHS Bhamarapravati N, Thammavit W, Vajrasthira S. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg 1978; 27: 787-94. Flavell DJ, Lucas SB. Promotion of N-nitrosodimethylamine initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorchis viverrini. Carcinogenesis 1983; 4: 927-30. Green A, Uttaravichien T, Bhudhisawasdi V, et al. Incidence and presentation of cholangiocarcinoma in North East Thailand: A Hospital-based study. Trap Geogr Med 1991; 43: 193-8. 89

Koompirochana C, Sonakul D, Chinda K, Stitnimankarn T. Opisthorchiasis: A clinicopathologic study of 154 autopsy cases. Southeast Asian J Trop Med Public Health 1978; 9: 60-4. Thamavit W, Bhamarapravati N, Sahaphong S, Vairasthira S, Angsubhakorn S. Effects of Dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini - Infected Syrian golden hamsters. Cancer Res 1978; 38: 4634-9. Thamavit W, Kongkanunt R, Tiwawech D, Moore MA. Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters. Virchows Arch 1987; 54: 52-8. Upatham ES, Viyanant V, Kurathong S, et al, Relation ship between prevalence and intensity of Opisthorchis viverrlni infection and clinical symptoms and signs in a rural community in Northeast Thailand. Bull WHO 1984; 62: 451-61. Vatanasap V, Titapant V, Tangvoraphongchai V, Pengsaa P. Cancer incidence in Khon Kaen Thailand: 1985-1988. Cancer Unit, Khon Kaen University 1988. Weinbren K, Mutum S. Pathological aspects of cholangiocarcinoma. J Patho11983; 139: 217-38. 90